loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for 09578_FLUKA

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    09578_FLUKA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Confirms Paragraph IV Patent Litigation for Lactic Acid, Citric Acid and Potassium Bitartrate
    FDA Confirms Paragraph IV Patent Litigation for Lactic Acid, Citric Acid and Potassium Bitartrate

    25 Apr 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-lactic-acid-citric-acid-and-potassium-bitartrate-85917.pdf

    FDA
    25 Apr 2023
    Share Share
    Evofem Biosciences receives US patent covering Phexxi composition of matter
    Evofem Biosciences receives US patent covering Phexxi composition of matter

    26 Sep 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153448&sid=2

    PHARMABIZ
    26 Sep 2022
    Share Share
    Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide
    Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

    16 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/large-commercial-payer-adds-phexxi-to-formulary-for-standard-plans-nationwide-301626008.html

    PRNEWSWIRE
    16 Sep 2022
    Share Share
    Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®
    Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

    10 May 2022

    // PRESS RELEASE

    https://evofem.investorroom.com/2022-05-10-Evofem-Biosciences-to-Decrease-Cost-of-Goods-45-Percent-Through-New-Partnership-with-Bora-Pharmaceutical-Services-for-the-Commercial-Manufacturing-of-Phexxi-R

    PRESS RELEASE
    10 May 2022
    Share Share
    Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi
    Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

    09 May 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/635113/evofem-s-phase-iii-trial-reveals-fewer-utis-women-using-phexxi

    PHARMAFILE
    09 May 2022
    Share Share
    Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021
    Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021

    19 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/evofem-biosciences-announces-record-net-sales-and-phexxi-prescriptions-in-q4-2021-301463762.html

    PRNEWSWIRE
    19 Jan 2022
    Share Share